URI graduate students launch pharmaceutical company

FROM LEFT, Nicholas DaSilva, Kenneth Rose and Benjamin Barlock, doctoral students at the University of Rhode Island’s College of Pharmacy, which is part of the Academic Health Collaborative, launched a drug development company, Alcinous. They discuss their venture in the pharmacy building on the Kingston Campus in early June. /COURTESY NORA LEWIS
FROM LEFT, Nicholas DaSilva, Kenneth Rose and Benjamin Barlock, doctoral students at the University of Rhode Island’s College of Pharmacy, which is part of the Academic Health Collaborative, launched a drug development company, Alcinous. They discuss their venture in the pharmacy building on the Kingston Campus in early June. /COURTESY NORA LEWIS
SOUTH KINGSTOWN – Three doctoral students at the University of Rhode Island’s College of Pharmacy have started a company that harnesses big data in a new approach to drug development. Nicholas DaSilva of Providence, Kenneth Rose of South Kingstown and Benjamin Barlock of Portland, Maine, founded Alcinous Pharmaceuticals late last year. David Worthen, a former College of Pharmacy faculty…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

No posts to display